News in the Life Sciences Industry

STOCKHOLM, Jan. 29, 2020 /PRNewswire/ -- Cyxone (publ), a Swedish biotech in autoimmune diseases, announced today that an order of more Rabeximod substance will be placed earlier than expected with the primary objective of providing optimal conditions for conducting the clinical phase IIb... Read more ››

STOCKHOLM, Jan. 28, 2020 /PRNewswire/ -- Essity has today raised EUR 300m in the bond market under its Euro Medium Term Note (EMTN) program. The reoffering yield for the bond was 0.58% with a maturity on February 3, 2030, corresponding to mid swaps +0.58 percentage points.

STOCKHOLM, Jan. 24, 2020 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm: ONCO) announces today that it will host a webcast at 11am (CET) on Monday, January 27(th) 2020 where CEO Jakob Lindberg will present and explain melflufen's mechanism of action.

GOTHENBURG, Sweden, Jan. 24, 2020 /PRNewswire/ -- Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL) today announced that the first patient in Australia has initiated treatment in the global Phase 3 AGENT study.

STOCKHOLM, Jan. 22, 2020 /PRNewswire/ -- JANUARY 1 - DECEMBER 31, 2019 (compared with the corresponding period a year ago)

STOCKHOLM, Jan. 22, 2020 /PRNewswire/ -- Calliditas Therapeutics AB (publ) ("Calliditas") today announced that the EMA Paediatric Committee (PDCO) has adopted a positive opinion on the Paediatric Investigation Plan (PIP) for Nefecon for the treatment of primary IgA nephropathy (IgAN).

UPPLANDS VÄSBY, Sweden, Jan. 22, 2020 /PRNewswire/ -- Envirotainer, the global market leader in secure cold chain solutions for air transport of pharmaceuticals, today announced that Eddy Cojulun joined Envirotainer as the new Chief Sales Officer (CSO) in December 2019. In his new role Eddy... Read more ››

LUND, Sweden, Jan. 22, 2020 /PRNewswire/ -- Hansa Biopharma will publish its Year-End report 2019 at 8:00 a.m. CET on February 6, 2020. All interested parties are invited to participate in a telephone conference, which will include a presentation of the interim results and a business update,... Read more ››

STOCKHOLM, Jan. 22, 2020 /PRNewswire/ -- Moberg Pharma AB (OMX: MOB) has now completed the expert evaluation of the results from the North American Phase 3-study. The analysis conducted with key opinion leaders (KOLs) has confirmed the validity of the data presented in December 2019 and increased... Read more ››

LINKÖPING, Sweden and ALMERE, the Netherlands, Jan. 22, 2020 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra... Read more ››